Irvin R, Wilton L, Scott H, Beauchamp G, Wang L, Betancourt J, Lubensky M, Wallace J, Buchbinder S . A Study of Perceived Racial Discrimination in Black Men Who Have Sex with Men (MSM) and Its Association with Healthcare Utilization and HIV Testing. AIDS Behav. 2014, 18: 1272-8
Jackson JB, Wei L, Liping F, Aramrattana A, Celentano DD, Walshe L, Xing Y, Richardson P, Jun M, Beauchamp G, Donnell D, Ruan Y, Ma L, Metzger D, Shao Y . Prevalence and seroincidence of hepatitis B and hepatitis C infection in high risk people who inject drugs in china and Thailand. Hepat Res Treat. 2014, 2014: 296958
James MM, Laeyendecker O, Sun J, Hoover DR, Mullis CE, Cousins MM, Coates T, Moore RD, Kelen GD, Fowler MG, Kumwenda JJ, Mofenson LM, Kumwenda NI, Taha TE, Eshleman SH . Antibody maturation and viral diversification in HIV-infected women. PLoS One. 2013, 8: e57350
Jennings L, Pettifor A, Hamilton E, Ritchwood TD, Xavier Gomez-Olive F, MacPhail C, Hughes JP, Selin A, Kahn K, HPTN 068 Study Team . Economic Resources and HIV Preventive Behaviors Among School-Enrolled Young Women in Rural South Africa (HPTN 068). AIDS Behav. 2017, 21: 665-677
Jennings L, Rompalo AM, Wang J, Hughes J, Adimora AA, Hodder S, Soto-Torres LE, Frew PM, Haley DF; HIV Prevention Trials Network (HPTN 064) Women’s HIV SeroIncidence Study (ISIS), Haley DF, HIV Prevention Trials Network (HPTN 064) Women’s HIV SeroIncidence Study (ISIS), HIV Prevention Trials Network (HPTN 064) Women’s HIV SeroIncidence Study . Prevalence and Correlates of Knowledge of Male Partner HIV Testing and Serostatus Among African-American Women Living in High Poverty, High HIV Prevalence Communities (HPTN 064). AIDS Behav. 2015, 19: 291-301
Jeremy Sugarman, Deborah J Donnell, Brett Hanscom, Marybeth McCauley, Beatriz Grinsztejn, Raphael J Landovitz, Sugarman J, Donnell DJ, Hanscom B, McCauley M, Grinsztejn B, Landovitz RJ . Ethical issues in establishing the efficacy and safety of long-acting injectable pre-exposure prophylaxis for HIV prevention: the HPTN 083 trial. Lancet HIV. 2021, 8: e723-e728
Jonathan Feelemyer, Typhanye V. Dyer, Rodman E. Turpin, Russell A. Brewer, Christopher Hucks-Ortiz, Willem F van Der Mei, Charles L. Cleland, Medha Mazumdar, Ellen C Caniglia, Amanda Geller, Joy D. Scheidell, Justin M. Feldman, Kenneth Mayer, Maria R. Khan . Longitudinal associations between the disruption of incarceration and community re-entry on substance use risk escalation among Black men who have sex with men; A causal analysis. Drug Alcohol Depend. 2020
Justman J, Befus M, Hughes J, Wang J, Golin CE, Adimora AA, Kuo I, Haley DF, Del Rio C, El-Sadr WM, Rompalo A, Mannheimer S, Soto-Torres L, Hodder S . Sexual Behaviors of US Women at Risk of HIV Acquisition: A Longitudinal Analysis of Findings from HPTN 064. AIDS Behavior. 2015, 19: 1327-37
Justman J, Goldberg A, Reed J, Bock N, Njeuhmeli E, Goldzier Thomas A . Adult male circumcision: reflections on successes and challenges. J Acquir Immune Defic Syndr. 2013, 63: S140-3
K Buchacz, J Farrior, G Beauchamp, L McKinstry, AE Kurth, BS Zingman, FM Gordin, D Donnell, KH Mayer, WM El-Sadr, B Branson . Changing Clinician Practices and Attitudes Regarding the Use of Antiretroviral Therapy for HIV Treatment and Prevention. J Int Assoc Physicians AIDS Care. 2017, 16: 81-90
K. Rivet Amico, Melissa Wallace, Linda-Gail Bekker, Surita Roux, Millicent Atujuna, Elaine Sebastian, Bonnie J. Dye, Vanessa Elharrar, Robert M. Grant, Amico KR, Wallace M, Bekker LG, Roux S, Atujuna M, Sebastian E, Dye BJ, Elharrar V, Grant RM . Experiences with HPTN 067/ADAPT Study-Provided Open-Label PrEP Among Women in Cape Town: Facilitators and Barriers Within a Mutuality Framework. AIDS and Behavior. 2017, 21: 1361-1375
Kaleebu P, Njai HF, Wang L, Jones N, Ssewanyana I, Richardson P, Kintu K, Emel L, Musoke P, Fowler MG, Ou SS, Jackson JB, Guay L, Andrew P, Baglyos L, Cao H; HPTN 027 protocol team . Immunogenicity of ALVAC-HIV vCP1521 in Infants of
HIV-1–Infected Women in Uganda (HPTN 027): The First
Pediatric HIV Vaccine Trial in Africa
. J Acquir Immune Defic Syndr. 2014, 65: 268-77
Kapadia SN, Wu C, Mayer KH, Wilkin TJ, Amico KR, Landovitz RJ, Andrade A, Chen YQ, Chege W, McCauley M, Gulick RM, Schackman BR . No change in health-related quality of life for at-risk U.S. women and men starting HIV pre-exposure prophylaxis (PrEP): Findings from HPTN 069/ACTG A5305. PLoS One. 2018, 13: e0206577
Karim QA, Baxter C, Karim SA . Topical microbicides--what's new?. J Acquir Immune Defic Syndr. 2013, 63: S144-9
Karuna S, Li SS, Grant S, Walsh SR, Frank I, Casapia M, Trahey M, Hyrien O, Fisher L, Miner MD, Randhawa AK, Polakowski L, Kublin JG, Corey L, Montefiori D, HVTN 405/HPTN 1901 Study Team . Neutralizing antibody responses over time in demographically and clinically diverse individuals recovered from SARS-CoV-2 infection in the United States and Peru: A cohort study. PLoS Med. 2021, 18: e1003868
Kawichai S, Celentano D, Srithanaviboonchai K, Wichajarn M, Pancharoen K, Chariyalertsak C, Visrutaratana S, Khumalo-Sakutukwa G, Sweat M, Chariyalertsak S; and The Project Accept Study Team . NIMH Project Accept (HPTN 043) HIV/AIDS Community Mobilization (CM) to Promote Mobile HIV Voluntary Counseling and Testing (MVCT) in Rural Communities in Northern Thailand: Modifications by Experience. AIDS Behav. 2012, 16: 1227-37
Kevany S, Khumalo-Sakutukwa G, Singh B, Chingono A, Morin S, NIMH Project Accept Study Team . Global Health Diplomacy, Monitoring & Evaluation, and the Importance of Quality Assurance & Control: Findings from NIMH Project Accept (HPTN 043). PLoS One. 2016, 11: e0149335
Kevany S, Sweat M, Singh B, Kulich M, Woelk G . Socio-economic status and health care utilization in rural Zimbabwe: Findings from Project Accept (HPTN 043). J of Public Health in Africa. 2012, 3: 46-51
Kevany S, Woelk G, Shade SB, Kulich M, Turan JM, Chingono A, Morin SF . Risk Factors for Physical Domestic Violence in a High-Prevalence HIV Setting: Findings from Project Accept Baseline Data (HPTN-043). J Public Health Africa. 2013, 4: e1
Khan MR, Brewer R, Abrams J, Mazumdar M, Scheidell JD, Feelemyer J, Dyer TV, Turpin RE, Hucks-Ortiz C, Gaydos CA, Severe M, Irvine NM, Kaufman JS, Cleland CM, Mayer KH . Incarceration and Sexual Risk Behavior and Incident Sexually Transmitted Infection/HIV in HPTN 061: Differences by Study City and Among Black Sexual Minority MSM, Black Sexual Minority MSM and Women, and Black Transgender Women. Sex Transm Dis. 2022, 49: 284-296
Kilburn K, Hughes JP, MacPhail C, Wagner RG, Gomez-Olive FX, Kahn K, Pettifor A . Cash Transfers, Young Women's Economic Well-Being, and HIV Risk: Evidence from HPTN 068. AIDS Behav. 2019, 23: 1178-1194
Kilburn K, Ranganathan M, Stoner MCD, Hughes JP, MacPhail C, Agyei Y, Gomez-Olive FX, Kahn K, Pettifor A . Transactional sex and incident HIV infection in a cohort of young women from rural South Africa. AIDS. 2018, 32: 1669-1677
Kilburn KN, Pettifor A, Edwards JK, Selin A, Twine R, MacPhail C, Wagner R, Hughes JP, Wang J, Kahn K . Conditional cash transfers and the reduction in partner violence for young women: an investigation of causal pathways using evidence from a randomized experiment in South Africa (HPTN 068). J Int AIDS Soc. 2018, 21 Suppl 1
Kintu K, Andrew P, Musoke P, Richardson P, Asiimwe-Kateera B, Nakyanzi T, Wang L, Fowler MG, Emel L, Ou SS, Baglyos L, Gurunathan S, Zwerski S, Jackson JB, Guay L . Feasibility and safety of ALVAC-HIV vCP1521 vaccine in HIV-exposed infants in Uganda: results from the first HIV vaccine trial in infants in Africa. J Acquir Immune Defic Syn. 2013, 63: 1-8
Kirkpatrick AR, Patel EU, Celum CL, Moore RD, Blankson JN, Mehta SH, Kirk GD, Margolick JB, Quinn TC, Eshleman SH, Laeyendecker O . Development and Evaluation of a Modified Fourth-Generation Human Immunodeficiency Virus Enzyme Immunoassay for Cross-Sectional Incidence Estimation in Clade B Populations. AIDS Res Hum Retroviruses. 2016, 32: 756-62
Kirkpatrick AR, Unsal AB, Blankson JN, Moore RD, Quinn TC, Hadigan C, Laeyendecker O . Weak HIV Antibody Responses in Perinatally Infected Young Adults: Weak HIV Antibody Responses in Perinatally Infected Adults. Pediatr Infect Dis J. 2017, 36: 1064-1066
Klock E, Wilson E, Fernandez RE, Piwowar-Manning E, Moore A, Kosloff B, Bwalya J, Bell-Mandla N, James A, Ayles H, Bock P, Donnell D, Fidler S, Hayes R, Eshleman SH, Laeyendecker O, HPTN 071 (PopART) study team . Validation of population-level HIV-1 incidence estimation by cross-sectional incidence assays in the HPTN 071 (PopART) trial.. J Int AIDS Soc. 2021, 24: e25830
Koblin BA, Mayer KH, Eshleman SH, Wang L, Mannheimer S, del Rio C, Shoptaw S, Magnus M, Buchbinder S, Wilton L, Liu TY, Cummings V, Piwowar-Manning E, Fields SD, Griffith S, Elharrar V, Wheeler D, for the HPTN 061 Protocol Team . Correlates of HIV Acquisition in a Cohort of Black Men
Who Have Sex with Men in the United States: HIV
Prevention Trials Network (HPTN) 061
. PLoS One. 2013, 8: e70413
Konikoff J, Brookmeyer R, Longosz AF, Cousins MM, Celum C, Buchbinder SP, Seage GR 3rd, Kirk GD, Moore RD, Mehta SH, Margolick JB, Brown J, Mayer KH, Koblin BA, Justman JE, Hodder SL, Quinn TC, Eshleman SH, Laeyendecker O . Performance of a limiting-antigen avidity enzyme immunoassay for cross-sectional estimation of HIV incidence in the United States. PLoS One. 2013, 8: e82772
Kuder M, Goheen MJ, Dize L, Barnes M, Gaydos CA . Evaluation of a new website design for iwantthekit for chlamydia, gonorrhea, and trichomonas screening. Sex Transm Dis. 2015, 42: 243-245
Kuo I, Golin CE, Wang J, Haley DF, Hughes J, Mannheimer S, Justman J, Rompalo A, Frew PM, Adimora AA, Soto-Torres L, Hodder S; HPTN 064 Study Team, Hodder S, HPTN 064 Study Team . Substance use patterns and factors associated with changes over time in a cohort of heterosexual women at risk for HIV acquisition in the United States. Drug Alcohol Depend. 2014, 139: 93-9
Kurth AE, Mayer K, Beauchamp G, McKinstry L, Farrior J, Buchacz K, Donnell D, Branson B, El-Sadr W; HPTN (065) TLC-Plus Study Team . Clinician practices and attitudes regarding early antiretroviral therapy in the United States. J Acquir Immune Defic Syndr. 2012, 61: e65-9
Lade JM, To EE, Hendrix CW, Bumpus NN . Discovery of Genetic Variants of the Kinases That Activate Tenofovir in a Compartment-specific Manner. EBioMedicine. 2015, 2: 1145-52
Laeyendecker O, Brookmeyer R, Cousins MM, Mullis CE, Konikoff J, Donnell D, Celum C, Buchbinder SP, Seage GR 3rd, Kirk GD, Mehta SH, Astemborski J, Jacobson LP, Margolick JB, Brown J, Quinn TC, Eshleman SH . HIV incidence determination in the United States: A multi-assay approach. J Infect Dis. 2013, 207: 232-9
Laeyendecker O, Konikoff J, Morrison DE, Brookmeyer R, Wang J, Celum C, Morrison CS, Abdool Karim Q, Pettifor AE, Eshleman SH . Identification and validation of a multi-assay algorithm for cross-sectional HIV incidence estimation in populations with subtype C infection. J Int AIDS Soc. 2018, 21
Laeyendecker O, Piwowar-Manning E, Fiamma A, Kulich M, Donnell D, Bassuk D, Mullis CE, Chin C, Swanson P, Hackett J Jr, et al . Estimation of HIV incidence in a large, community-based, randomized clinical trial: NIMH project accept (HIV Prevention Trials Network 043). PLoS One. 2013, 8: e68349
Laeyendecker O, Redd AD, Nason M, Longosz AF, Karim QA, Naranbhai V, Garrett N, Eshleman SH, Abdool Karim SS, Quinn TC . Antibody Maturation in Women Who Acquire HIV Infection While Using Antiretroviral Preexposure Prophylaxis. J Infect Dis. 2015, 212: 754-9
Lancaster KE, Hoffman IF, Hanscom B, Ha TV, Dumchev K, Susami H, Rose S, Go VF, Reifeis SA, Mollan KR, Hudgens MG, Piwowar-Manning EM, Richardson P, Dvoriak S, Djoerban Z, Kiriazova T, Zeziulin O, Djauzi S, Ahn CV, Latkin C, Metzger D, Burns DN, Sugarman J, Strathdee SA, Eshleman SH, Clarke W, Donnell D, Emel L, Sunner LE, McKinstry L, Sista N, Hamilton EL, Lucas JP, Duong BD, Van Vuong N, Sarasvita R, Miller WC, HPTN 074 Study Team . Regional differences between people who inject drugs in an HIV prevention trial integrating treatment and prevention (HPTN 074): a baseline analysis. J Int AIDS Soc. 2018, 21: e25195
Lancaster KE, Miller WC, Kiriazova T, Sarasvita R, Bui Q, Ha TV, Dumchev K, Susami H, Hamilton EL, Rose S, Hershow RB, Go VF, Metzger D, Hoffman IF, Latkin CA . Designing an Individually Tailored Multilevel Intervention to Increase Engagement in HIV and Substance Use Treatment Among People Who Inject Drugs With HIV: HPTN 074. AIDS Educ Prev. 2019, 31: 95-110
Landovitz R, Donnell D, Clement M, Hanscom B, Cottle L, Coelho L, Landovitz RJ, Clement ME, Cabello R, Chariyalertsak S, Dunne EF, Frank I, Gallardo-Cartagena JA, Gaur AH, Gonzales P, Tran HV, Hinojosa JC, Kallas EG, Kelley CF, Losso MH, Madruga JV, Middelkoop K, Phanuphak N, Santos B, Sued O, Valencia Huamani J, Overton ET, Swaminathan S, Del Rio C, Gulick RM, Richardson P, Sullivan P, Piwowar-Manning E, Marzinke M, Hendrix C, Li M, Wang Z, Marrazzo J, Daar E, Asmelash A, Brown TT, Anderson P, Eshleman SH, Bryan M, Blanchette C, Lucas J, Psaros C, Safren S, Sugarman J, Scott H, Eron JJ, Fields SD, Sista ND, Gomez-Feliciano K, Jennings A, Kofron RM, Holtz TH, Shin K, Rooney JF, Smith KY, Spreen W, Margolis D, Rinehart A, Adeyeye A, Cohen MS, McCauley M, Grinsztejn B, Team HS . Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women [HPTN 083]. NEJM. 2021, 385: 595-608
Landovitz RJ, Li S, Grinsztejn B, Dawood H, Liu AY, Magnus M, Hosseinipour MC, Panchia R, Cottle L, Chau G, Richardson P, Marzinke MA, Hendrix CW, Eshleman SH, Zhang Y, Tolley E, Sugarman J, Kofron R, Adeyeye A, Burns D, Rinehart AR, Margolis D, Spreen WR, Cohen MS, McCauley M, Eron JJ . Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial. PLoS Med. 2018, 15: e1002690
Landovitz RJ, Zangeneh SZ, Chau G, Grinsztejn B, Eron JJ, Dawood H, Liu AY, Panchia R, Hosseinipour MC, Kofron R, Margolis DA, Rinehart A, Adeyeye A, Burns D, McCauley M, Cohen MS, Currier JS . Cabotegravir is Not Associated with Weight Gain in HIV-uninfected Individuals in HPTN 077. Clin Infect Dis. 2019
Lao-Tzu Allan-Blitz, Timothy W Menza, Vanessa Cummings, Charlotte A Gaydos, Leo Wilton, Kenneth H Mayer . Differing Correlates of Incident Bacterial Sexually Transmitted Infections Among a Cohort of Black Cisgender Men Who Have Sex With Men and Transgender Women Recruited in 6 US Cities (HIV Prevention Trials Network 061). Sexually Transmitted Diseases. 2022, 49: e79-e84
Latkin C1, Donnell D, Liu TY, Davey-Rothwell M, Celentano D, Metzger D, Latkin C . The dynamic relationship between social norms and behaviors: the results of an HIV prevention network intervention for injection drug users. Addiction. 2013, 108: 934-43
Latkin CA, Van Tieu H, Fields S, Hanscom BS, Connor M, Hanscom B, Hussen SA, Scott HM, Mimiaga MJ, Wilton L, Magnus M, Chen I, Koblin BA . Social Network Factors as Correlates and Predictors of High Depressive Symptoms Among Black Men Who Have Sex with Men in HPTN 061. AIDS Behav. 2017, 21: 1163-1170
Lawrence Corey, M.D., Peter B. Gilbert, Ph.D., Michal Juraska, Ph.D., David C. Montefiori, Ph.D., Lynn Morris, Ph.D., Shelly T. Karuna, M.D., Srilatha Edupuganti, M.D., Nyaradzo M. Mgodi, M.B., Ch.B., M.Med., Allan C. deCamp, Ph.D., Erika Rudnicki, M.S., . Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition. N Engl J Med. 2021, 384: 1003-1014
Leddy AM, Lippman SA, Neilands TB, Twine R, Ahern J, Gomez-Olive FX, DeLong SM, MacPhail C, Kahn K, Pettifor AE . Community collective efficacy is associated with reduced physical intimate partner violence (IPV) incidence in the rural province of Mpumalanga, South Africa: findings from HPTN 068. J Epidemiol Community Health. 2019, 73: 176-181
Leddy AM, Selin A, Lippman SA, Kimaru LJ, Twine R, Gómez-Olivé X, Kahn K, Pettifor A . Emotional Violence is Associated with Increased HIV Risk Behavior Among South African Adolescent Girls and Young Women in the HPTN 068 Cohort.. AIDS Behav. 2022, 26: 1863-1870
Levy ME, Phillips G 2nd, Magnus M, Kuo I, Beauchamp G, Emel L, Hucks-Ortiz C, Hamilton EL, Wilton L, Chen I, Mannheimer S, Tieu HV, Scott H, Fields SD, Del Rio C, Shoptaw S, Mayer K . A Longitudinal Analysis of Treatment Optimism and HIV Acquisition and Transmission Risk Behaviors Among Black Men Who Have Sex with Men in HPTN 061. AIDS and Behavior. 2017, 21: 2958-2972
Lewis MK, Hsieh YH, Gaydos CA, Peterson SC, Rothman RE . Informed consent for opt-in HIV testing via tablet kiosk: an assessment of patient comprehension and acceptability. Int J STD AIDS. 2017, 28: 1292-1298
Lippman SA, Leddy AM, Neilands TB, Ahern J, MacPhail C, Wagner RG, Peacock D, Twine R, Goin DE, Gomez-Olive FX, Selin A, Tollman SM, Kahn K, Pettifor A . Village community mobilization is associated with reduced HIV incidence in young South African women participating in the HPTN 068 study cohort. J Int AIDS Soc. 2018, 21 Suppl 7: e25182
Lise Jaimeson, Leigh F Johnson, Brooke E Nichols, Sinead Delany-Moretlwe, Mina C Hosseinipour, Colin Russell, Gesine Meyer-Rath . Relative cost-effectiveness of long-acting injectable cabotegravir versus oral pre-exposure prophylaxis in South Africa based on the HPTN 083 and HPTN 084 trials: a modelled economic evaluation and threshold analysis. Lancet HIV.
London AJ, Borasky DA Jr, Bhan A; Ethics Working Group of the HIV Prevention Trials Network, Bhan A, Ethics Working Group of the HIV Prevention Trials Network . Improving ethical review of research involving incentives for health promotion. PLoS Med. 2012, 9: e1001193
Longosz AF, Mehta S, Kirk GD, Margolick JB, Brown J, Quinn TC, Eshleman SH, Laeyendecker O . Incorrect identification of recent HIV infection in adults in the United States using a limiting-antigen avidity assay. AIDS. 2014, 28: 1227-32
Longosz AF, Morrison CS, Chen P-L, Arts E, Nankya I, Salata RA, Franco V, Quinn TC, Eshleman SH, Laeyendecker O, Chen PL . Immune responses in Ugandan women infected with subtypes A and D HIV using the BED capture immunoassay and an antibody avidity assay. J Acquir Immune Defic Syndr. 2014, 65: 390-6
Longosz AF, Morrison CS, Chen PL, Brand HH, Arts E, Nankya I, Salata RA, Quinn TC, Eshleman SH, Laeyendecker O . Comparison of antibody responses to HIV infection in Ugandan women infected with HIV subtypes A and D. AIDS Res Hum Retroviruses. 2015, 31: 421-7
Longosz AF, Serwadda D, Nalugoda F, Kigozi G, Franco V, Gray RH, Quinn TC, Eshleman SH, Laeyendecker O . Impact of HIV subtype on performance of the limiting antigen-avidity enzyme immunoassay, the bio-rad avidity assay, and the BED capture immunoassay in Rakai, Uganda. AIDS Res Hum Retroviruses. 2014, 30: 339-44
Lucas GM, Beauchamp G, Aramrattana A, Shao Y, Liu W, Fu L, Jackson JB, Celentano DD, Richardson P, Metzger D; for the HPTN 058 study group . Short-term safety of buprenorphine/naloxone in HIV-seronegative opioid-dependent Chinese and Thai drug injectors enrolled in HIV Prevention Trials Network 058. Int J Drug Policy. 2012, 23: 162-5
Lucas GM, Young A, Donnell D, Richardson P, Aramrattana A, Shao Y, Ruan Y, Liu W, Fu L, Ma J, Celantano D, Metzger D, Jackson JB, Burns D, HPTN 058 study group . Hepatotoxicity in a 52-week randomized trial of short-term versus long-term treatment with buprenorphine/naloxone in HIV-negative injection opioid users in China and Thailand. Drug Alcohol Depend. 2014, 142: 139-45
Lynch BA, Patel EU, Courtney CR, Nanfack AJ, Bimela J, Wang X, Eid I, Quinn TC, Laeyendecker O, Nyambi PN, Duerr R, Redd AD . Short Communication: False Recent Ratio of the Limiting-Antigen Avidity Assay and Viral Load Testing Algorithm Among Cameroonians with Long-Term HIV Infection. AIDS Res Hum Retroviruses. 2017, 33: 1114-1116
Macleod D, Shanaube K, Skalland T, Limbada M, Mandla N, Bwalya J, Schaap A, Yang B, Donnell D, Piwowar-Manning E, Eshleman SH, Hoddinott G, Bond V, Moore A, Griffith S, Bock P, Ayles H, Fidler S, Hayes R, Floyd S; HPTN 071 (PopART) Study Team. . Viral suppression and self-reported ART adherence after 3 years of universal testing and treatment in the HPTN 071 (PopART) community-randomised trial in Zambia and South Africa: a cross-sectional analysis. Lancet HIV. 2022, 9: e751-e759
MacPhail C, Khoza N, Selin A, Julien A, Twine R, Wagner RG, Gomez-Olive X, Kahn K, Wang J, Pettifor A . Cash transfers for HIV prevention: what do young women spend it on? Mixed methods findings from HPTN 068.. BMC Public Health. 2017, 18: 10
MacRegga Severe, Joy D. Scheidell, Typhanye V. Dyer, Russell A. Brewer, Alberta Negri, Rodman E. Turpin, Kailyn E. Young, Christopher Hucks-Ortiz, Charles M. Cleland, Kenneth Mayer, Maria R. Khan . Lifetime Burden of Incarceration and Violence, Internalized Homophobia, and HIV/STI Risk among Black Men who Have Sex with Men in the HPTN 061 Study. AIDS Behavior. 2021, 25: 1507-1517
Magidson JF, Li X, Mimiaga MJ, Moore AT, Srithanaviboonchai K, Friedman RK, Limbada M, Hughes JP, Cummings V, Gaydos CA, Elharrar V, Celentano D, Mayer KH, Safren SA . Antiretroviral Medication Adherence and Amplified HIV Transmission Risk Among Sexually Active HIV-Infected Individuals in Three Diverse International Settings. AIDS and Behavior. 2016, 20: 699-709
Magnus M, Franks J, Griffith S, Arnold MP, Goodman K, Wheeler DP; for the HPTN 061 Study Group, Wheeler DP, HPTN 061 Study Group . Engaging, Recruiting, and Retaining Black Men Who Have Sex With Men in Research Studies: Don't Underestimate the Importance of Staffing-Lessons Learned From HPTN 061, the BROTHERS Study. J Public Health Manag Pract. 2014, 20: E1-9
Mahiane SG, Laeyendecker O . Segmented polynomials for incidence rate estimation from prevalence data. Stat Med. 2017, 36: 334-344
Maman S, van Rooyen H, Stankard P, Chingono A, Muravha T, Ntogwisangu J, Phakathi Z, Srirak N, Morin S; NIMH Project Accept (HPTN 043) study team . NIMH Project Accept (HPTN 043): results from in-depth interviews with a longitudinal cohort of community members. PLoS One. 2014, 9: e87091
Mannheimer S, Hirsch-Moverman Y, Franks J, Loquere A, Hughes JP, Li M, Amico KR, Grant RM . Factors Associated With Sex-Related Pre-exposure Prophylaxis Adherence Among Men Who Have Sex With Men in New York City in HPTN 067. J Acquir Immune Defic Syndr. 2019, 80: 551-558
Mannheimer S, Wang L, Wilton L, Tieu HV, Del Rio C, Buchbinder S, Fields S, Glick S, Conor MB, Cummings V, Eshleman SH, Koblin B, Mayer KH . Infrequent HIV Testing and Late HIV Diagnosis Are Common Among US Black Men Who Have Sex with Men (BMSM). J Acquir Immune Defic Syndr. 2014, 67: 438-45
Margolick JB, Bream JH, Martinez-Maza O, Lopez J, Li X, Phair JP, Koletar SL, Jacobson LP . Frailty and Circulating Markers of Inflammation in HIV+ and HIV- Men in the Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr. 2017, 74: 407-417
Margolick JB, Bream JH, Nilles TL, Li H, Langan SJ, Deng S, Wang R, Wada N, Leng SX . Relationship Between T-Cell Responses to CMV, Markers of Inflammation, and Frailty in HIV-uninfected and HIV-infected Men in the Multicenter AIDS Cohort Study. J Infect Dis. 2018, 218: 249-258
Marzinke M, Breaud A, Parsons TL, Cohen MS, Piwowar-Manning E, Eshleman SH, Clarke W . The development and validation of a method using high-resolution mass spectrometry (HRMS) for the qualitative detection of antiretroviral agents in human blood. Clin Chim Acta. 2014, 10: 157-68
Marzinke MA, Clarke W, Wang L, Cummings V, Liu TY, Piwowar-Manning E, Breaud A, Griffith S, Buchbinder S, Shoptaw S, del Rio C, Magnus M, Mannheimer S, Fields SD, Mayer KH, Wheeler DP, Koblin BA, Eshleman SH, Fogel JM . Nondisclosure of HIV status in a clinical trial setting: antiretroviral drug screening can help distinguish between newly diagnosed and previously diagnosed HIV infection. Clin Infect Dis. 2014, 58: 117-20
Mayer KH, Maslankowski LA, Gai F, El-Sadr WM, Justman J, Kwiecien A, Masse B, Eshleman SH, Hendrix C, Morrow K, Rooney JF, Soto-Torres L; HPTN 050 Protocol Team . Safety and tolerability of tenofovir vaginal gel in abstinent and sexually active HIV-infected and uninfected women. AIDS. 2006, 20: 543-51 PMID: 16470118
Mayer KH, Wang L, Koblin B, Mannheimer S, Magnus M, del Rio C, Buchbinder S, Wilton L, Cummings V, Watson CC, Piwowar-Manning E, Gaydos C, Eshleman SH, Clarke W, Liu TY, Mao C, Griffith S, Wheeler D; HPTN061 Protocol Team, Wheeler D, HPTN 061 Protocol Team . Concomitant socioeconomic, behavioral, and biological factors associated with the disproportionate HIV infection burden among Black men who have sex with men in 6 U.S. cities. PLoS One. 2014, 9: e87298
Mayer KH, Wheeler DP, Bekker LG, Grinsztejn B, Remien RH, Sandfort TG, Beyrer C . Overcoming biological, behavioral, and structural vulnerabilities: new directions in research to decrease HIV transmission in men who have sex with men. J Acquir Immune Defic Syndr. 2013, 63: S161-7
Mayer KH, Yuhas K, Amico KR, Wilkin T, Landovitz RJ, Richardson P, Marzinke MA, Hendrix CW, Eshleman SH, Cottle LM, Marcus C, Chege W, Rinehart AR, Rooney JF, Andrew P, Salata RA, Magnus M, Farley JE, Liu AY, Frank I, Ho K, Santana J, Stekler JD, Chen YQ, McCauley M, Gulick RM, HPTN 069/ACTG 5305 Study Team . Sexual behavior and medication adherence in men who have sex with men participating in a pre-exposure prophylaxis study of combinations of Maraviroc, Tenofovir Disoproxil Fumarate and/or Emtricitabine (HPTN 069/ACTG 5305). AIDS Behav.
McGowan I, Wilkin T, Landovitz RJ, Wu C, Chen Y, Marzinke MA, Hendrix CW, Richardson P, Eshleman SH, Andrade A, Chege W, Anderson PL, McCauley M, Farley J, Mayer KH, Anton P, Brand RM, Cranston RD, Gulick R . The pharmacokinetics, pharmacodynamics, and mucosal responses to maraviroc-containing pre-exposure prophylaxis regimens in MSM. AIDS. 2019, 33: 237-246
McKay HS, Margolick JB, Martinez-Maza O, Lopez J, Phair J, Rappocciolo G, Denny TN, Magpantay LI, Jacobson LP, Bream JH . Multiplex assay reliability and long-term intra-individual variation of serologic inflammatory biomarkers. Cytokine. 2017, 90: 185-192
McKinstry LA, Zerbe A, Farrior J, Kurth AE, Stanton J, Li M, Elion R, Leider J, Branson B, El-Sadr WM, Hanscom B, for the HPTN 065 Study, Kurth A, Li Maoji . A Randomized-Controlled Trial of Computer-based Prevention Counseling for HIV-Positive Persons (HPTN 065). 2017
Melendez JH, Hardick J, Barnes M, Barnes P, Geddes CD, Gaydos CA . Molecular Characterization of Markers Associated With Antimicrobial Resistance in Neisseria gonorrhoeae Identified From Residual Clinical Samples. Sex Transm Dis. 2018, 45: 312-315
Metzger DS, Donnell D, Celentano DD, Jackson JB, Shao Y, Aramrattana A, Wei L, Fu L, Ma J, Lucas GM, Chawarski M, Ruan Y, Richardson P, Shin K, Chen RY, Sugarman J, Dye BJ, Rose SM, Beauchamp G, Burns DN; HPTN 058 Protocol Team, Burns DN, HPTN 058 Protocol Team . Expanding Substance Use Treatment Options for HIV Prevention With Buprenorphine-Naloxone: HIV Prevention Trials Network 058. JAIDS. 2015, 68: 554-61
Mgodi NM, Takuva S, Edupuganti S, Karuna S, Andrew P, Lazarus E, Garnett P, Shava E, Mukwekwerere PG, Karg C, Tindale I, Greene E, Luthuli N, Baepanye K, Hural J, Gomez Lorenzo MM, Burns D, Miner MD, Ledgerwood J, Mascola JR, Donnell D, Cohen MS, Corey L, HVTN 703/HPTN 081 Team . A Phase 2b Study to Evaluate the Safety and Efficacy of VRC01 Broadly Neutralizing Monoclonal Antibody in Reducing Acquisition of HIV-1 Infection in Women in Sub-Saharan Africa: Baseline Findings. J Acquir Immune Defic Syndr. 2021, 87: 680-687
Miller L, Prieto Merino D, Baisley K, Hayes R. . Hidden heterogeneity: Uncovering patterns of adherence in microbicide trials for HIV prevention.. PLoS One. , 17: e0267011
Miller WC, Hoffman IF, Hanscom BS, Ha TV, Dumchev K, Djoerban Z, Rose SM, Latkin CA, Metzger DS, Lancaster KE, Go VF, Dvoriak S, Mollan KR, Reifeis SA, Piwowar-Manning E, Richardson P, Hudgens MG, Hamilton EL, Sugarman J, Eshleman SH, Susami H, Chu VA, Djauzi S, Kiriazova T, Bui DD, Strathdee SA, Burns DN . A scalable, integrated intervention to engage people who inject drugs in HIV care and medication-assisted treatment (HPTN 074): a randomised, controlled phase 3 feasibility and efficacy study. Lancet. 2018, 392: 747-759
Mirochnick M, Taha T, Kreitchmann R, Nielsen-Saines K, Kumwenda N, Joao E, Pinto J, Santos B, Parsons T, Kearney B, Emel L, Herron C, Richardson P, Hudelson SE, Eshleman SH, George K, Fowler MG, Sato P, Mofenson L; HPTN 057 Protocol Team . Pharmacokinetics and safety of tenofovir in HIV-infected women during labor and their infants during the first week of life. J Acquir Immune Defic Syndr. 2014, 65: 33-41
Mitchell K, Dimitrov D, Hughes J, Moore M, Vittinghoff E, Liu A, Cohen M, Beyrer C, Donnell D, Boily MC . Assessing the use of surveillance data to estimate the impact of prevention interventions on HIV incidence in cluster-randomized controlled trials. 2020
Mitchell KM, Dimitrov D, Hughes JP, Xia F, Donnell D, Amico KR, Bokoch K, Chitwarakorn A, Bekker LG, Holtz TH, Mannheimer S, Grant RM, Boily MC . In what circumstances could non-daily pre-exposure prophylaxis for HIV substantially reduce program costs?. AIDS. 2018, 32: 809-818
Mitchell KM, Hoots B, Dimitrov D, German D, Flynn C, Farley JE, Gelman M, Hughes JP, Donnell D, Adeyeye A, Remien RH, Beyrer C, Paz-Bailey G, Boily MC . Improvements in the HIV Care Continuum Needed to Meaningfully Reduce HIV Incidence Among Men Who Have Sex with Men in Baltimore, US: A Modelling Study for HPTN 078. J Int AIDS Soc. 2019, 22: e25246
Mohammed Limbada, David Macleod, Vasty Situmbeko, Ellen Muhau, Osborn Shibwela, Bwalya Chiti, Sian Floyd, Albertus J Schaap, Richard Hayes, Sarah Fidler, Helen Ayles . Rates of viral suppression in a cohort of people with stable HIV from two community models of ART delivery versus facility-based HIV care in Lusaka, Zambia: a cluster-randomised, non-inferiority trial nested in the HPTN 071 (PopART) trial. Lancet HIV. 2021, 9: E13-E23
Momplaisir, F., Hussein, M., Tobin-Fiore, D., Smith, L., Bennett, D., Latkin, C., Metzger, D. S. . Racial Inequities in HIV Prevalence and Composition of Risk Networks Among People Who Inject Drugs in HIV Prevention Trial Network 037. J Acquir Immune Defic Syndr. 2018, 76: 394-401
Montgomery BE, Rompalo A, Hughes J, Wang J, Haley D, Soto-Torres L, Chege W, Justman J, Kuo I, Golin C, Frew P, Mannheimer S, Hodder S . Violence Against Women in Selected Areas of the United States. Am J Public Health. 2015, 105: 2156-66
Moore JR, Donnell DJ, Boily MC, Mitchell KM, Delany-Moretlwe S, Bekker LG, Mgodi NM, El-Sadr W, Cohen MS, Celum CL, Dimitrov D . Model-Based Predictions of HIV Incidence Among African Women Using HIV Risk Behaviors and Community-Level Data on Male HIV Prevalence and Viral Suppression [HPTN 082]. Journal of Acquired Immune Deficiency Syndromes. 2020, 85: 423-429